GSK expects sales, profit toward top of 2025 forecasts despite tariff, pipeline pressures
By Pushkala Aripaka and Maggie Fick (Reuters) -GSK expects to deliver annual sales and profit growth towards the top end of its forecasts after beating second-quarter expectations on Wednesday, in a boost to its efforts to fuel growth despite product development and tariff challenges. The British drugmaker is hoping to reach annual sales of over …








